Better funding needed for chronic disease

February 06, 2006

More funding, increased workforce resources and further reform of the health system are needed if the national chronic disease strategy is going to deliver better care to patients suffering from diseases such as diabetes, asthma and cancer, according to an international primary health expert.

The National Chronic Disease Strategy had its "heart in the right place", but would only work well with a "substantial amount of thought about resource implications across the board", according to Professor Christopher Dowrick, a Visiting Fellow at the Australian Primary Health Care Research Institute at ANU.

Professor Dowrick, who is also Professor of Primary Medical Care at the University of Liverpool, has examined the Australian strategy, with an eye to chronic disease care in the UK and US.

With the rates of chronic disease growing, and with an ageing population, chronic disease is becoming a major focus in health care.

The National Chronic Disease Strategy is a framework for care and prevention of chronic disease in Australia. Following a development process, the Australian Health Ministers last year endorsed the national strategic approach to chronic disease prevention and care.

In a seminar at ANU today, Professor Dowrick said resources like workforce numbers, information technology systems and the funding of multidisciplinary teams would all need to be considered to ensure the strategy benefits patients.

"The chronic disease strategy could have substantial implications for primary care in Australia, including a more multidisciplinary team approach and a shift in GP payment methods from a fee-for-service to a managed care model," Professor Dowrick said. "The strategy's incorporation of mental health with other chronic disease is a particularly good element of this model."

However, Professor Dowrick, a practising GP and editor of the journal Chronic Illness, said the national strategy also implies individuals will have to monitor their own health and may give GPs an opportunity to opt out of care for patients who are not keeping to the prescribed guidelines.

"That's not to say GPs would do that, but it may give them the option of taking a 'care-by-guidelines' approach," Professor Dowrick said. But the most important part of the strategy was ensuring it is used to manage inequalities in health care, he said.

"It's not only about resource allocation at a State or Federal level, it should also be about proper resource allocation in funding general practice to offer this care for patients of chronic disease.

"Given the right setting and viewing the strategy as a long-term plan, it could be an effective tool in improving the health care of Australians with chronic disease in the future," Professor Dowrick said.
Amanda Morgan
Media Adviser
The Australian National University
T: 02 6125 5575
F: 02 6125 8255
M: 0416 249 245
Marketing & Communications Division The Australian National University Canberra ACT 0200 Australia

Research Australia

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to